Covered recipient · General Payments record
ALEXIS LAMIE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$4,792.38
- Reported across 105 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,438.01 | 53 |
| Education | $99.94 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $292.71 | 12 |
| Acerta Pharma LLC | $273.72 | 8 |
| JAZZ PHARMACEUTICALS INC. | $125.00 | 1 |
| E.R. Squibb & Sons, L.L.C. | $122.01 | 1 |
| PFIZER INC. | $82.79 | 4 |
| Blueprint Medicines Corporation | $50.38 | 2 |
| Daiichi Sankyo Inc. | $46.49 | 2 |
| Incyte Corporation | $38.04 | 2 |
| Gilead Sciences, Inc. | $37.62 | 2 |
| SOBI, INC | $35.06 | 2 |
| Genmab U.S., Inc. | $31.14 | 1 |
| ABBVIE INC. | $31.12 | 1 |
| GENZYME CORPORATION | $30.60 | 1 |
| Ipsen Biopharmaceuticals, Inc | $29.71 | 1 |
| TerSera Therapeutics LLC | $29.36 | 1 |
| Janssen Biotech, Inc. | $28.39 | 1 |
| Regeneron Healthcare Solutions, Inc. | $26.91 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.83 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $25.48 | 1 |
| EISAI INC. | $24.43 | 1 |
| BeiGene USA, Inc. | $23.94 | 1 |
| ADC Therapeutics America, Inc. | $22.16 | 1 |
| SpringWorks Therapeutics, Inc. | $22.13 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.14 | 1 |
| Immunocore Limited | $16.93 | 1 |
| Agios Pharmaceuticals, Inc. | $16.40 | 1 |
| ARRAY BIOPHARMA INC | $16.38 | 1 |
| Astellas Pharma US Inc | $13.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.